The State Directed Payment NPRM Is Not Just About States
CMS published a 192-page proposed rule for the Medicare Drug Price Negotiation Program on June 12, 2026. The proposed rule is published in the Federal Register and is open for public comment for 60 days. The comment period will close on August 17, 2026. The CMS has proposed a framework to make the Medicare Drug Price Negotiation Program permanent, aiming to negotiate prices for high-cost drugs starting in 2029, capping Medicaid managed care payments at Medicare rate levels. This proposed rule is designed to lock in lower prices for single-source drugs and includes policies for ongoing negotiation. The compliance weight falls on plans that never set the rates in the first place.
A Narrow 2017 Exception That Became the Backbone of Medicaid Managed Care Financing
State directed payments were codified in federal regulation in 2017. The mechanism allows state Medicaid agencies to require managed care organizations to pay providers at rates above what plans would otherwise negotiate. The intent was narrow: direct additional resources to safety net hospitals, rural facilities, and nursing homes that carry disproportionate Medicaid patient loads.
What followed was not a targeted correction. It was a structural transformation. Two states used the mechanism in 2016. Forty-one states use it today. State directed payment spending grew to at least $38.5 billion in 2022. CMS projects spending to exceed $144.6 billion in FY2026. The Congressional Budget Office revised its 10-year Medicaid spending projections upward by $267 billion, attributing roughly half of that increase to directed payment growth.
The financing mechanism compounded the problem. States funded the nonfederal share of directed payments largely through provider taxes rather than general fund appropriations. This reduced states’ direct fiscal stake while substantially increasing federal outlays. The GAO characterized the oversight framework in December 2023 as having weak fiscal guardrails.
Projected state directed payment spending in FY2026 — a mechanism that did not exist in 2016 and was supposed to remain a narrow exception to managed care payment rules.
The Rate Caps, the Grandfathering Window, and What 29 States Are Looking At
The NPRM proposes extending rate limits to all state directed payments and certain targeted fee-for-service payments. The rationale traces directly to the GAO’s December 2023 findings: CMS had never defined what “reasonable and appropriate” means, and states had been using commercial rate benchmarks that substantially exceed Medicare levels.
A KFF analysis of approved SDP arrangements found that 29 states would likely need to reduce existing payment rates to comply. Twenty-four states have at least one directed payment raising reimbursement above 90 percent of average commercial rates — levels substantially above the proposed Medicare-based caps. The analysis found that some states benchmark SDPs to as much as 100 percent of average commercial rates, which are considerably higher than Medicare in most hospital markets.
The grandfathering provision provides a runway: SDPs submitted or approved before July 4, 2025, may remain in place through rating periods beginning January 1, 2028. After that date, phased reductions apply until arrangements reach the proposed caps. For managed care organizations, this is not a waiver. It is a compliance timeline with a hard endpoint that requires planning to begin now.
CMS estimates $775 billion in total savings over 10 years if the rule is finalized as proposed, including $510 billion in federal savings. The scale of those projections reflects how far state directed payments have grown beyond their 2017 origins as a narrowly defined exception to managed care payment rules.
The MCO Governance Gap: Executing What You Cannot Control
Under federal regulation at 42 CFR 438.6(c), states may direct managed care organizations to make specific payments to specific providers at specific rates. The plan has no discretion about whether to comply. It is a contractual conduit between the state’s payment instruction and the provider’s bank account.
That passivity has consequences now that the payment structure is being capped. Managed care organizations built capitation rate models assuming certain directed payment flows. Their actuarial submissions reflected provider access built in part on SDP-supported payment levels. Provider contracts in many networks reference specific directed payment benchmarks. When those levels decline, the financial architecture that rested on them shifts accordingly.
The NPRM’s grandfathering provisions do not eliminate the compliance obligation. They create a deadline. Plans that have not begun auditing their SDP exposure by the time the rule finalizes are starting too late. An SDP inventory is the starting point: which directed payments apply to this plan, what preprint governs each arrangement, what benchmark was used, and what is the effective date?
A grandfathering analysis follows: which SDPs were submitted or approved before July 4, 2025, and what would the phasedown schedule require after the grandfathering period expires? A capitation adequacy review is necessary: were current actuarial submissions built on payment rate assumptions that include SDP levels above the proposed caps? And a provider contract review is overdue in most organizations: do existing network agreements reference specific directed payment levels, and what amendment authority applies when those levels change?
Two Tracks, Two Timelines, and the Provider Tax Compounding Effect
The NPRM does not operate in isolation. The House passed the One Big Beautiful Bill Act in May 2025, with CBO projecting $793 billion in federal Medicaid reductions over 10 years. Roughly 10 percent of those savings came from an SDP cap on future hospital and nursing facility payments — applicable to new SDPs only, with existing arrangements permitted to remain.
The Senate Finance Committee’s draft reconciliation language is more aggressive: it would reduce existing SDPs by 10 percent annually until they reach the statutory caps. If this approach advances, MCOs would face two overlapping compliance frameworks with different phasedown schedules, neither of which the plan controls.
State directed payments are frequently financed through provider taxes. Hospitals pay a tax into state Medicaid funds; states use it as their required cost share to draw down federal matching dollars; the federal match exceeds the tax; the MCO is directed to return the inflated total to the provider. Both reconciliation bills include separate provisions to cap provider taxes.
If provider tax revenues decline at the same time SDP payment rates are capped, the financing infrastructure that supported elevated provider payments constricts from two directions simultaneously. Capitation rates built on provider access assumptions that included SDP-supported payment levels may no longer reflect achievable network adequacy in affected markets.
Complete an SDP inventory: which directed payments apply, what preprint governs each, what benchmark was used, and what is the effective date? Follow with a grandfathering analysis and a capitation adequacy review. Then review provider contracts for any references to specific directed payment benchmarks and determine what amendment authority applies.
The comment period on CMS-2449-P is also an engagement opportunity. MCOs in the 29 likely-affected states have specific operational concerns — capitation rate adequacy, provider contract amendments, actuarial recalculations — that are relevant to CMS rulemaking and that most plans are unlikely to formally document unless prompted.
The NPRM is a public comment opportunity before it becomes a compliance obligation. The legislative trajectory in both chambers targets the same mechanism. The GAO flagged the oversight failure in 2023. The CBO revised its projections upward because of this problem. The question was never whether this would be addressed. The question was when, and whether plans would have their compliance infrastructure ready when it was.
States built this system. Managed care organizations executed it. The restructuring, though, requires MCO governance to absorb what state policy built. Until next week, stay briefed.
Why This Matters
Five reasons this NPRM is a structural compliance event for Medicaid managed care organizations, not a state policy story.
Questions Leaders Should Ask Now
Eight questions for compliance, finance, and operations leaders at Medicaid managed care organizations.